/
/
/

Onesource Specialty Pharma Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
₹516 Cr₹449 Cr₹428 Cr₹290 Cr₹376 Cr₹327 Cr₹426 Cr₹393 Cr₹334 Cr₹292 Cr₹73 Cr₹56 Cr₹34 Cr
₹95 L₹4 Cr₹2 Cr₹5 Cr₹3 Cr₹5 Cr₹3 Cr₹7 Cr₹4 Cr₹4 Cr₹3 Cr₹1 Cr₹9 L
₹517 Cr₹453 Cr₹430 Cr₹295 Cr₹379 Cr₹333 Cr₹429 Cr₹399 Cr₹338 Cr₹296 Cr₹76 Cr₹57 Cr₹34 Cr
₹428 Cr₹397 Cr₹408 Cr₹343 Cr₹339 Cr₹307 Cr₹312 Cr₹319 Cr₹325 Cr₹296 Cr₹95 Cr₹86 Cr₹91 Cr
₹164 Cr₹127 Cr₹94 Cr₹22 Cr₹110 Cr₹94 Cr₹185 Cr₹149 Cr₹82 Cr₹68 Cr-₹16 L-₹9 Cr-₹38 Cr
₹35 Cr₹31 Cr₹23 Cr₹38 Cr₹34 Cr₹27 Cr₹33 Cr₹46 Cr₹45 Cr₹42 Cr₹20 Cr₹26 Cr₹25 Cr
₹53 Cr₹20 Cr-₹29 L-₹93 Cr₹6 Cr-₹4 Cr₹84 Cr-₹67 Cr-₹37 Cr-₹47 Cr-₹40 Cr-₹161 Cr-₹87 Cr
₹57 Cr₹25 Cr₹5 Cr-₹89 Cr₹10 Cr-₹19 L₹99 Cr-₹69 Cr-₹42 Cr-₹6 Cr-₹40 Cr-₹130 Cr-₹114 Cr

Share Price Live Stats

Open (₹)1,585.40
Volume (₹)2.05 L
High (₹)1,591.30
Upper Circuit1,882.40
Low (₹)1,566.00
Lower Circuit1,255.00
Prev Close1,568.70
52W High (₹)1,917.80
Price1,586.00
52W Low (₹)1,057.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)17970.00 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.22
Price to Book2.90
Book Value508.17
EPS (TTM)-0.14
Face Value1.00
ROE (%)-1.26

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
ONESOURCENSE
LTP
1W Low
1W High
Market cap (₹)
1790.2+12.5 (0.70%)
1722
1810.40
4,25,150Cr
10027.5+247.5 (2.53%)
9863
10067
2,66,265Cr
4660.9+47.5 (1.03%)
4553
4685.60
1,76,301Cr
2332.2-73.3 (-3.05%)
2252.40
2441.90
1,25,352Cr
1262.3+16.8 (1.35%)
1217.20
1266.60
1,23,591Cr
1370.4+18.4 (1.36%)
1336.70
1376.70
1,14,351Cr
1396.7+17.8 (1.29%)
1364.60
1400.80
1,12,474Cr
2488.8-4 (-0.16%)
2457.90
2512.30
1,02,315Cr
1704.7+23.3 (1.39%)
1656.20
1713.80
97,757Cr
2043.4+32.4 (1.61%)
1988.90
2062.10
92,007Cr
1586+23 (1.47%)
1535.50
1601.50
17,970Cr

Key Highlights of Onesource Specialty Pharma Ltd’s P&L

In 2026-03-31, Onesource Specialty Pharma Ltd reported total revenue of ₹1468.05Cr, compared with ₹1465.04Cr in 2025-03-31, reflecting Onesource Specialty Pharma Ltd turnover.

Depreciation was ₹279.09Cr and finance costs were ₹122.19Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹-₹91.96Cr in 2026-03-31 as compared to ₹-₹67.07Cr in 2025-03-31.

Net Profit (PAT) was ₹-₹73.8Cr in 2026-03-31 compared with ₹-₹17.97Cr in 2025-03-31.

Earnings per share (EPS) were ₹-6.44 in 2026-03-31, compared with ₹-1.57 in 2025-03-31.